Both serous intraepithelial carcinoma and endometrial glandular dysplasia are associated
with uterine serous carcinoma. Recently a candidate serous cancer precursor containing …

Alteration of p53 is an early event in the development of endometrial serous carcinoma
(ESC). We have recently identified a group of benign-looking endometria with p53 …

Uterine serous carcinoma (USC) is an uncommon but aggressive type of endometrial cancer
associated with rapid progression of disease and a poor prognosis. Both USC and its …

Serous endometrial intraepithelial carcinoma is often associated with extrauterine disease. It
is currently unclear where does the extrauterine disease come from. This study addressed …

To determine if selected cases of uterine serous carcinoma (USC) arise from tubal rather
than endometrial epithelium. Bilateral fallopian tubes from 38 women with pure USC were …

Uterine serous carcinoma (USC) is an uncommon but aggressive type of endometrial
carcinoma that is frequently associated with extrauterine disease despite minimal or no …

An aberrant p53 immunophenotype may be identified in several histotypes of endometrial
carcinoma, and is accordingly recognized to lack diagnostic specificity in and of itself …

Abstract Purpose: Endometrial glandular dysplasia (EmGD) has been recently proposed to
be a putative precursor to endometrial serous carcinoma (ESC). The purpose of this study is …

Most serous adenocarcinomas involving both the endometrium and ovary are presumed to
arise in the endometrium. Recently, serous tubal intraepithelial carcinoma (STIC) has been …

Endometrial serous carcinomas constitute no more than 10% of endometrial
adenocarcinomas, but frequently present at an advanced stage and have a significantly …